Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000184315 | SCV000236940 | pathogenic | not provided | 2013-04-08 | criteria provided, single submitter | clinical testing | c.52012_52034delinsAACCCT: p.Asp17338AsnfsX18 (D17338NfsX18) in exon 241 of the TTN gene (NM_001256850.1). The normal sequence with the bases that are deleted in braces and inserted in brackets is: ATCA{del23}[AACCCT]AATT. The c.52012_52034del23insAACCCT mutation in the TTN gene has not been reported previously as a disease-causing mutation or as a benign polymorphism, to our knowledge. This mutation causes a shift in reading frame starting at codon Aspartic acid 17338, changing it to a Asparagine, and creating a premature stop codon at position 18 of the new reading frame, denoted p.Asp17338AsnfsX18. This mutation is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Other truncating TTN variants have been reported in approximately 3% of control alleles (Herman D et al., 2012). However, the c.52012_52034del23insAACCCT mutation is located in the A-band region of titin, where the majority of truncating mutations associated with DCM have been reported (Herman D et al., 2012). In summary, c.52012_52034del23insAACCCT in the TTN gene is interpreted as a disease-causing mutation. The variant is found in DCM panel(s). |